Combined with HSDL2 knockdown and overexpression assays in melanoma cells, the data confirmed the positive role of HSDL2 in melanoma proliferation and apoptotic inhibition, suggesting that silencing HSDL2 may be a potential strategy for blocking melanoma progression. The gene discussed is HSDL2; the disease is melanoma.